title: Characterization of 5-fluorouracil microspheres for colonic delivery.
abstract: The purpose of this investigation was to prepare and evaluate the colon-specific microspheres of 5-fluorouracil for the treatment of colon cancer. Core microspheres of alginate were prepared by the modified emulsification method in liquid paraffin and by cross-linking with calcium chloride. The core microspheres were coated with Eudragit S-100 by the solvent evaporation technique to prevent drug release in the stomach and small intestine. The microspheres were characterized by shape, size, surface morphology, size distribution, incorporation efficiency, and in vitro drug release studies. The outer surfaces of the core and coated microspheres, which were spherical in shape, were rough and smooth, respectively. The size of the core microspheres ranged from 22 to 55 microm, and the size of the coated microspheres ranged from 103 to 185 microm. The core microspheres sustained the drug release for 10 hours. The release studies of coated microspheres were performed in a pH progression medium mimicking the conditions of the gastrointestinal tract. Release was sustained for up to 20 hours in formulations with core microspheres to a Eudragit S-100 coat ratio of 1:7, and there were no changes in the size, shape, drug content, differential scanning calorimetry thermogram, and in vitro drug release after storage at 40 degrees C/75% relative humidity for 6 months.
authors.affiliation: Department of Pharmaceutics, F/O Pharmacy, Hamdard University, New Delhi-110063 India. ziyaur_rahman2@rediffmail.com
authors.forename: Ziyaur
authors.initials: Z
authors.lastname: Rahman
authors.forename: Kanchan
authors.initials: K
authors.lastname: Kohli
authors.forename: Roop K
authors.initials: RK
authors.lastname: Khar
authors.forename: Mushir
authors.initials: M
authors.lastname: Ali
authors.forename: Naseem A
authors.initials: NA
authors.lastname: Charoo
authors.forename: Areeg A A
authors.initials: AA
authors.lastname: Shamsher
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry; D003106:Colon / Q000737:chemistry*; D003110:Colonic Neoplasms / Q000188:drug therapy; D003692:Delayed-Action Preparations / Q000032:analysis / Q000737:chemistry*; D004353:Drug Evaluation, Preclinical; D005472:Fluorouracil / Q000008:administration & dosage* / Q000032:analysis / Q000737:chemistry*; D005766:Gastrointestinal Contents / Q000737:chemistry*; D006801:Humans; D008422:Materials Testing; D008863:Microspheres; D010316:Particle Size; D014677:Pharmaceutical Vehicles / Q000737:chemistry*; D013608:Tablets, Enteric-Coated / Q000032:analysis / Q000737:chemistry*
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D014677:Pharmaceutical Vehicles; D013608:Tablets, Enteric-Coated; D005472:Fluorouracil